4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-019841
CHIEF OPERATING OFFICER sold 18,900 shares at $28.72 ($542,808)
- CHIEF OPERATING OFFICER acquired 6,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2025-07-14 | Option exercise 10b5-1 | +6,500 | $8.83 | $57,395 | 68,063 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-07-14 | Sale 10b5-1 | −18,900 | $28.72 | $542,808 | 49,163 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-07-14 | Option exercise · Share Option 10b5-1 | −6,500 | 32,000 | D | ||
| Open-market sales · 18,900 sh · avg $28.72 · $542,808 | |||||||
Loading xslF345X05/form4-07162025_040704.xml…